W.W. Grainger, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10722
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

W.W. Grainger, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

W.W. Grainger, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

W.W. Grainger, Inc. (Grainger or “the company”) is a broad-line distributor of maintenance, repair and operating (MRO) supplies and other related products and services to businesses and institutions. The company primarily operates in the US and Canada with presence in Europe, Asia and Latin America. It is headquartered in Lake Forest, Illinois.

Scope

- Detailed information on W.W. Grainger, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting W.W. Grainger, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of W.W. Grainger, Inc. including a breakdown and examination of key business segments
- Intelligence on W.W. Grainger, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about W.W. Grainger, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of W.W. Grainger, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess W.W. Grainger, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on W.W. Grainger, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
W.W. Grainger, Inc.: Company Overview 9
W.W. Grainger, Inc.: Overview and Key Facts 9
W.W. Grainger, Inc.: Overview 9
W.W. Grainger, Inc.: Key Facts 9
W.W. Grainger, Inc.: Key Employees 11
W.W. Grainger, Inc.: Key Employee Biographies 12
W.W. Grainger, Inc.: Major Products and Services 17
W.W. Grainger, Inc.: Company History 19
W.W. Grainger, Inc.: Management Statement 23
W.W. Grainger, Inc.: Locations and Subsidiaries 26
W.W. Grainger, Inc.: Key Competitors 27
W.W. Grainger, Inc.: Company Analysis 28
W.W. Grainger, Inc.: Business Description 28
W.W. Grainger, Inc.: SWOT Analysis 30
W.W. Grainger, Inc.: SWOT Overview 30
W.W. Grainger, Inc.: Strengths 30
W.W. Grainger, Inc.: Weaknesses 31
W.W. Grainger, Inc.: Opportunities 31
W.W. Grainger, Inc.: Threats 32
W.W. Grainger, Inc.: Corporate Financial Deals Activity 34
W.W. Grainger, Inc.: Financial Deals Overview 34
W.W. Grainger, Inc.: Targets and Partners 35
W.W. Grainger, Inc.: Top Deals 2014 – 2018YTD* 36
W.W. Grainger, Inc.: Advisors 37
W.W. Grainger, Inc.: Top Legal Advisors 37
W.W. Grainger, Inc.: Top Financial Advisors 37
W.W. Grainger, Inc.: Mergers and Acquisitions 38
W.W. Grainger, Inc.: Capital Raising 39
W.W. Grainger, Inc.: Divestments 40
W.W. Grainger, Inc.: Recent Developments 41
W.W. Grainger, Inc.: News and Events Summary 41
W.W. Grainger, Inc.: Business Expansion 43
W.W. Grainger, Inc.: Corporate Governance 44
W.W. Grainger, Inc.: Corporate Social Responsibility 45
W.W. Grainger, Inc.: Financial Performance 45
W.W. Grainger, Inc.: Strategy and Operations 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: W.W. Grainger, Inc.: Key Facts
Table 2: W.W. Grainger, Inc.: Key Employees
Table 3: W.W. Grainger, Inc.: Company History
Table 4: W.W. Grainger, Inc.: Locations and Subsidiaries
Table 5: W.W. Grainger, Inc.: Key Competitors
Table 6: W.W. Grainger, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: W.W. Grainger, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: W.W. Grainger, Inc.: Targets and Partners
Table 9: W.W. Grainger, Inc.: Top Deals 2014 - 2018YTD*
Table 10: W.W. Grainger, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: W.W. Grainger, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: W.W. Grainger, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: W.W. Grainger, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: W.W. Grainger, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: W.W. Grainger, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: W.W. Grainger, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: W.W. Grainger, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 18: W.W. Grainger, Inc.: News and Events Summary
Table 19: W.W. Grainger, Inc.: Business Expansion
Table 20: W.W. Grainger, Inc.: Corporate Governance
Table 21: W.W. Grainger, Inc.: Corporate Social Responsibility
Table 22: W.W. Grainger, Inc.: Financial Performance
Table 23: W.W. Grainger, Inc.: Strategy and Operations

List of Figures
Figure 1: W.W. Grainger, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: W.W. Grainger, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: W.W. Grainger, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: W.W. Grainger, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: W.W. Grainger, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: W.W. Grainger, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: W.W. Grainger, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 8: W.W. Grainger, Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[W.W. Grainger, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cielo Wind Power LP:企業の戦略的SWOT分析
    Cielo Wind Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Haier Smart Home Co Ltd (600690):企業の財務・戦略的SWOT分析
    Haier Smart Home Co Ltd (600690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Goals Soccer Centres plc (GOAL):企業の財務・戦略的SWOT分析
    Goals Soccer Centres plc (GOAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • InSphero AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • Allenex AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Allenex AB (Allenex), formerly LinkMed AB, a subsidiary of CareDx Inc, is a blood stemcells and organs transplantation service provider. The company offers olerup SSP and absorber. Its oleruu is used before the transplantation. Allenex offers pre transplantation, transplantation and post tra …
  • Nikon Corporation:戦略・SWOT・企業財務分析
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Tokyo Star Bank Ltd:企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析
    Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務分析
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AB SKF (SKF B):企業の財務・戦略的SWOT分析
    AB SKF (SKF B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Apotex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and d …
  • Aluminum Corporation of China Ltd:企業の戦略・SWOT・財務情報
    Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Astex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Groupe SMCP S.A.S.:企業の戦略的SWOT分析
    Groupe SMCP S.A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Huneed Technologies:企業の戦略・SWOT・財務情報
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Natsionalna Elektricheska Kompania EAD:企業の戦略的SWOT分析
    Natsionalna Elektricheska Kompania EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Arris International Plc:企業の戦略・SWOT・財務情報
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆